Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fiacitabine (NSC-382097) 是单纯疱疹病毒 (HSV) DNA 复制的选择性抑制剂,对 HSV1和 HSV2的 IC50分别为2.5 nM 和12.6 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,330 | 现货 | ||
5 mg | ¥ 2,890 | 现货 | ||
10 mg | ¥ 4,160 | 现货 | ||
25 mg | ¥ 6,520 | 现货 | ||
50 mg | ¥ 8,790 | 现货 | ||
100 mg | ¥ 11,800 | 现货 | ||
500 mg | ¥ 23,700 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 3,110 | 现货 |
产品描述 | Fiacitabine (NSC-382097) is a selective inhibitor of DNA replication of the herpes simplex virus(HSV) (IC50: 2.5 nM and 12.6 nM for HSV1 and HSV2, respectively). |
靶点活性 | HSV1:2.5 nM, HSV2:12.6 nM |
体外活性 | FIAC was active at much lower concentrations than arabinosylcytosine, iododeoxyuridine, and arabinosyladenine. It was slightly more active against herpes simplex virus type 1 than acycloguanosine and slightly more toxic to normal cells. FIAC was about 8,000 times more active against the replication of wild-type herpes simplex virus type 1 than against a mutant strain lacking the expression of a virus-specified thymidine kinase. HSV FIAC suppressed by 90% the replication of various strains of herpes simplex virus types 1 and 2 at concentrations of 0.0025 to 0.0126 microM. Cytotoxicity was minimal, as determined by trypan blue dye exclusion with norman Vero, WI-38, and NC-37 cell proliferation; the 50% inhibitory dose was 4 to 10 microM in a 4-day assay [2]. |
别名 | 非西他滨, FOAC, FIAC, NSC 382097 |
分子量 | 371.1 |
分子式 | C9H11FIN3O4 |
CAS No. | 69123-90-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 35 mg/mL (94.31 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.6947 mL | 13.4735 mL | 26.9469 mL | 67.3673 mL |
5 mM | 0.5389 mL | 2.6947 mL | 5.3894 mL | 13.4735 mL | |
10 mM | 0.2695 mL | 1.3473 mL | 2.6947 mL | 6.7367 mL | |
20 mM | 0.1347 mL | 0.6737 mL | 1.3473 mL | 3.3684 mL | |
50 mM | 0.0539 mL | 0.2695 mL | 0.5389 mL | 1.3473 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Fiacitabine 69123-90-6 Microbiology/Virology HSV 非西他滨 NSC382097 NSC-382097 Herpes simplex virus FOAC inhibit FIAC NSC 382097 Inhibitor inhibitor